Additional information
Colourless Liquid
1346602-59-2
ACI-020231
C16H25NO5
311.37
Ambient
2-8°C
Antihypertensive
Pharmaceutical Impurity Standards
N-[2-Hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]formamide
N-[2-Hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]formamide
N-[2-Hydroxy-3-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]propyl]formamide





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)